Jimmy Fund Blog Stories, News, and Highlights

cancer immunotherapies

Dana-Farber/Brigham and Women’s Cancer Center to launch nation’s first tissue-screening program for immunotherapies

Dana-Farber/Brigham and Women’s Cancer Center (DF/BWCC) will become the first treatment center in the United States to routinely test patients’ tumor tissue to determine whether the cancer is likely to respond to immunotherapies. The testing, expected to begin in early…

ContinueDana-Farber/Brigham and Women’s Cancer Center to launch nation’s first tissue-screening program for immunotherapies